The Jerusalem PostPalestinian election candidate warns West Bank could ‘explode’ unless Israel releases tax fundsESPN Deportes¿Quién es el hacker que destapó el dopaje financiero del Man. City?InquirerUnhealthy air quality for sensitive groups in parts of Metro Manila – DENRRTP DesportoEm ambiente conturbado. Portugal defronta Dinamarca após saída de Cristiano RonaldoESPNJoey Porter Jr. traded: What move means for Cowboys, SteelersDaily MaverickLOCAL ELECTIONS 2026: Navigating ballots, candidates, and wards: Your guide to the 2026 local government electionsVarietyParamount, CNN Chief Mark Thompson in ‘Early Stages’ of Discussions to Keep Him in PostIl Sole 24 OreStadi e concerti, con le ondate di calore i raduni accrescono rischi e decessiRai NewsChioggia, viene rimproverato dal padre e lo ferisce con un utensile da cucina: 17enne in casermaSportstarSouth Africa World Cup 2027 Schedule: Full Fixtures, Dates, Venues and OpponentsBBC NewsBurnham's Man City comments 'completely out of touch', Tories sayCBS NewsBolivia's attorney general arrested for alleged money laundering, drug trafficking
The Daily Newsstand · Free, Always
Thursday, October 1, 2026

These ten healthcare stocks posted the biggest one-month losses

Translate
Heart Health Concept

Eoneren/E+ via Getty Images

As the month of September 2026 comes to a close, the broader stock market has exhibited a mix of late-summer consolidation and selective sector rotation.

Investors continue to digest shifting macroeconomic data and adjust their portfolios for the final stretch of the third quarter, creating a dynamic backdrop where individual stock picking and sector trends take center stage. Within this environment, several pocket-level opportunities have emerged, particularly in healthcare-related assets.

Below is a list of the worst performing healthcare stocks over the past one month. The list is ranked based on lowest one month price performance, with all stocks currently holding a Hold Quant Rating from Seeking Alpha's Quant Ratings system.

The list is topped by Liquidia Corporation (LQDA), with a one month price performance of -55.30%. Dyne Therapeutics, Inc. (DYN) and Structure Therapeutics Inc. (GPCR) are next, with Acadia Pharmaceuticals Inc. (ACAD) and Ionis Pharmaceuticals, Inc. (IONS) rounding out the rest of the top five.

The bottom performers span the pharmaceuticals and biotechnology industries, with The Cooper Companies, Inc. (COO) representing health care supplies as the lone diversified name on the list.

Here is the list:

  1. Liquidia Corporation (LQDA), 1 month performance percentage: -55.30%

  2. Dyne Therapeutics, Inc. (DYN), 1 month performance percentage: -35.74%

  3. Structure Therapeutics Inc. (GPCR), 1 month performance percentage: -33.99%

  4. Acadia Pharmaceuticals Inc. (ACAD), 1 month performance percentage: -30.78%

  5. Ionis Pharmaceuticals, Inc. (IONS), 1 month performance percentage: -26.86%

  6. Arrowhead Pharmaceuticals, Inc. (ARWR), 1 month performance percentage: -22.92%

  7. Immunome, Inc. (IMNM), 1 month performance percentage: -21.98%

  8. Enliven Therapeutics, Inc. (ELVN), 1 month performance percentage: -20.77%

  9. The Cooper Companies, Inc. (COO), 1 month performance percentage: -20.57%

  10. Erasca, Inc. (ERAS), 1 month performance percentage: -18.69%

Health Care ETFs: (XLV), (VHT), (IHI), (IXJ), (IYH), (FHLC), and (FXH)

View the original on Seeking Alpha →

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.